Lyme Disease Testing Industry Expected to Reach $15.11 Billion by 2029 at 9.1% CAGR

Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.

Lyme Disease Testing Market Value Projection: How Much Will the Market Size by 2025?
In the last few years, the market size for Lyme disease testing has seen significant growth. The market, valued at $9.77 billion in 2024, is expected to expand to $10.68 billion in 2025, showing a compound annual growth rate (CAGR) of 9.3%. Several factors have contributed to this growth during the historical period, including the increased demand for early detection of disease, the proliferation of sophisticated diagnostic tools, the rise in tick populations due to climatic variations, enhanced government spending on controlling vector-borne diseases, and the development of healthcare infrastructure in rural areas and regions where the disease is prevalent.

What Will Be the Market Growth Forecat for Lyme Disease Testing in 2029?
Forecasts predict that the market size of Lyme disease testing will experience significant growth in the coming years. By 2029, it will expand to $15.11 billion, with a compound annual growth rate (CAGR) of 9.1%. This growth during the forecast period is resultant of several factors, including increased travel to regions where the disease is endemic, a surge in the usage of multiplex diagnostic technologies, a growing number of outdoor activities, an upward demand for testing kits that can be used at home, and escalating worries concerning co-infections with other diseases from ticks. The projected trends for the forecast period are advancements in molecular diagnostic techniques, progress in research on biomarkers, innovative technology in point-of-care testing devices, developments in lab-on-a-chip (microfluidic) technology, and advances in immunoassay technologies.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/lyme-disease-testing-global-market-report

What Are the Core Competitive Drivers in the Lyme Disease Testing Industry?
The growth of the lyme disease testing market is anticipated to be driven by the increasing instances of illnesses transmitted by ticks. Tick-borne illnesses encompass a collection of diseases spread to humans through bites from infected ticks, these parasitic creatures predominantly inhabit grassy, forested, or rural locations. The need for treatments for these illnesses is on a gradual rise due to the growing geographical spread of ticks, which can be attributed to climate change, resulting in escalated exposure and infection rates. Tick-borne illnesses significantly impact the demand for Lyme disease testing as they are the main transmission route for Lyme disease. This calls for prompt detection and diagnosis to efficiently control creeping infection cases. As an example, the Centers for Disease Control and Prevention, an American federal public health institute, reported 71,346 tick-borne disease cases in July 2024, a significant surge from the 36,177 cases in 2021. Consequently, the increasing occurrence of tick-borne illnesses propels the growth of the lyme disease testing market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25817&type=smp

Which Lyme Disease Testing Market Segment Is Projected to See the Fastest Growth?
The lyme disease testing market covered in this report is segmented -

1) By Test Type: Serological Tests, Nucleic Acid Tests, Urine Antigen Tests, Other Test Types
2) By Testing Methodology: Enzyme-Linked Immunosorbent Assay (ELISA), Weste Blot, Polymerase Chain Reaction (PCR), Immunofluorescence Assay (IFA), Other Emerging Technologies
3) By Disease Stage: Early Lyme Disease, Disseminated Lyme Disease, Chronic Lyme Disease, Asymptomatic Lyme Disease Detection
4) By Sample Type: Blood, Urine, Cerebrospinal Fluid(CSF), Other Blood Samples
5) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Research Institutions, Public Health Organizations

Subsegments:
1) By Serological Tests: Enzyme-Linked Immunosorbent Assay, Western Blot, Immunofluorescence Assay (IFA), Line Immunoassay (LIA)
2) By Nucleic Acid Tests: Polymerase Chain Reaction (PCR), Loop-Mediated Isothermal Amplification (LAMP), Next-Generation Sequencing (NGS)
3) By Urine Antigen Tests: Lateral Flow Assay, Enzyme Immunoassay (EIA), Immunoblot Urine Tests
4) By Other Test Types: Culture-Based Tests, Tick-Borne Co-Infection Panels, Artificial Intelligence-Assisted Diagnostic Tools

Which Trends Are Opening New Opportunities in the Lyme Disease Testing Market?
Key players in the Lyme disease testing market are emphasizing on improving the technology of their diagnostic tools to boost test precision, decrease processing times, and facilitate the early detection of the disease. Diagnostic tools encompass medical appliances, kits, or technologies dedicated to recognizing Lyme disease by finding unique antibodies, antigens, or DNA linked to the Borrelia burgdorferi bacteria. For example, in August 2024, EpitogenX Ltd., a biotech firm based in the UK, unfolded a state-of-the-art Lyme Disease Diagnostic Kit. This ELISA-based test is designed using their unique EpitoGen platform, integrates approximately 120 differential Borrelia epitopes, and provides high selectivity and sensitivity customized for research application (RUO). This kit enables early, strain-specific identification and can be adapted to unique laboratory uses. Primarily developed for research and diagnostic labs, it is perfectly suited for inflating detection precision and providing profound understanding into Lyme disease.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25817&type=smp

Who Are the Leaders in the Lyme Disease Testing Market?
Major companies operating in the lyme disease testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific, BIOMÉRIEUX, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A, Meridian Bioscience, Everlywell, Trinity Biotech, T2 Biosystems, IGeneX, Viramed Biotech AG, Ceres Nanosciences, Galaxy Diagnostics, Novatein Biosciences, Lyme Diagnostics Ltd

Which Regional Lyme Disease Testing Markets Offer the Greatest Growth Potential?
North America was the largest region in the lyme disease testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyme disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out to Us Speak With Our Expert: Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.